Hepatology· 2018Q1
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- 4,301citations
- Q1SCImago
- 2018year
Short summary
The AASLD 2018 Hepatitis B Guidance updates recommendations for chronic hepatitis B (CHB), including new treatment options like tenofovir alafenamide, and guidance on screening, prevention, specialized testing, monitoring, and treatment in special populations.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Epidemiology
EpidemiologyMedicine